Target Species
Chickens (breeders and layers).
Indications for use
For the active immunisation of chickens from 6 weeks of age to reduce colonisation and faecal excretion of S. Enteritidis (serogroup D), S. Typhimurium and S. Heidelberg (serogroup B), S. Infantis, S. Hadar and S. Virchow (serogroup C).
Onset of immunity after the second vaccination
− S. Enteritidis, S. Typhimurium, S. Infantis, S. Hadar and S. Virchow: 4 weeks
− S. Heidelberg: 9 weeks*
*Earliest timepoint investigated
Duration of immunity after the second vaccination
− S. Enteritidis: 48 weeks (evidenced by challenge) and 90 weeks (evidenced by serology)
− S. Typhimurium: 57 weeks (evidenced by challenge) and 90 weeks (evidenced by serology)
− S. Infantis: 51 weeks (evidenced by challenge)
− S. Hadar: 51 weeks (evidenced by challenge)
− S. Virchow: 51 weeks (drawn from scientific reasoning)
− S. Heidelberg: 57 weeks (drawn from scientific reasoning)
Contraindications
None.
Special warnings for each target species
Vaccinate healthy animals only.
Special precautions for use
Not applicable.
Operator warnings
In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician.
Adverse Reactions
Chickens:
Very Common (> 1 animal / 10 animals treated): | Decreased activity1 Reduced food intake1 Injection site nodule2 |
1 May last up to 2 days after the first vaccination
2 ≤ 8 mm in size; may be present up to 2 weeks after the second vaccination
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or its local representative or the national competent authority via the national reporting system. See section “Contact details” of the package leaflet.
Use during pregnancy or lactation
Laying birds:
Do not use in birds in lay and within 3 weeks before the start of the laying period.
Interactions
No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.
Amounts to be administered and administration route
For Intramuscular use:
Shake well before use. Syringes and needles must be sterile before use. Follow standard aseptic procedures.
Intramuscular injection of one dose of 0.5 ml from 6 weeks of age followed by a second vaccination with one dose of 0.5 ml at least 4 weeks later. The second vaccination should be administered no later than 3 weeks before the onset of lay.
Hygiene measures and good husbandry practices should also play an important part of a control programme to reduce the incidence of Salmonella infection.
Overdose
No data available.
Withdrawal period
Zero days.